Bionano Laboratories offers innovative testing solutions designed to advance genetic testing applications for health care providers, researchers, and industry partners. Our new CLIA facility in San Diego as well other facilities across the globe will allow us to offer exceptional testing services while introducing transformative new technologies to the genomics landscape. These new capabilities will allow Bionano Laboratories to uncover more answers than ever before.
Our clinical testing services, previously known as Lineagen, was incorporated in 2006 while collaborating with two leading autism research facilities, the University of Utah and the Children’s Hospital of Philadelphia (CHOP), to pioneer important research identifying novel genetic markers associated with autism spectrum disorders (ASD)3-6, and subsequently started offering clinical testing for patients specializing on neurodevelopmental disorders in 2010. Acquired by Bionano Genomics in 2020, Lineagen has continued to offer a guideline-driven test menu and support services that can be leveraged to assist families along every step of the diagnostic testing process. Now doing business as Bionano Laboratories, Lineagen’s previous clinical testing services will be combined with the abilities of a new CLIA and CAP certified laboratory in San Diego to create a new enhanced organization to serve as a source of innovation within the genomics industry. Providing both clinical testing via laboratory developed tests (LDTs) and research and data services leveraging optical genome mapping, our laboratory is an ideal testing partner.
Vice President of Laboratory Business
Justin Leighton has spent his last ten-plus years working in the diagnostic testing industry providing him with a diverse background in marketing, operations, IT, and commercial leadership. He joined Bionano Laboratories in 2021, bringing his passion of delivering exceptional diagnostic services to both health care providers and patients. Before joining Bionano Laboratories, Justin served in leadership roles at several large diagnostic companies, including PerkinElmer and GeneDx. Justin is a certified genetic counselor who received a master’s degree from Arcadia University and a bachelor’s degree in Diagnostic Genetic Sciences from the University of Connecticut.Read More
Clinical Laboratory Director
Dr. Hovanes received her B.S. degree in Genetics from the University of California, Davis and her Ph.D. in Molecular Biology from the University of California, Irvine. She completed her clinical cytogenetics and clinical molecular genetics trainings at the Cedars-Sinai Medical Center and University of California Los Angeles Intercampus Medical Genetics Training Program. She is a diplomat of the American Board of Medical Genetics as a Clinical Cytogeneticist and Clinical Molecular Geneticist. Over her twenty-year career in clinical diagnostics, she has held leadership roles in several laboratories providing molecular and cytogenetic testing in prenatal, pediatric, miscarriage analysis, preimplantation genetic testing, noninvasive prenatal screening, and oncology. With deep technical and clinical knowledge, she has extensive experience in collaborating with executive teams, medical teams, research and development departments, client services, and sales and marketing for strategic planning, expanding test offering, designing and implementing validation projects, and improving quality management programs.Read More
Senior Clinical Laboratory Director
Dr. Sahoo is a board-certified clinical cytogeneticist with over 18 years of experience in the field. He received his undergraduate and graduate medical education in India and completed his postdoctoral training in microbiology and human genetics at Duke University. In 2008, Dr. Sahoo joined Baylor College of Medicine as a faculty member in the Department of Human and Molecular Genetics. He also served as an ABMGG fellow in clinical cytogenetics at Baylor Genetics Laboratories. During this time, he was an integral part of the early design, validation, and implementation of array comparative genomic hybridization (CGH) for postnatal and prenatal clinical testing. He also played a key role in the discovery of several microdeletion/microduplication syndromes and the genetic basis of Prader-Willi syndrome. Over the past 18 years, Dr. Sahoo has held senior leadership positions at several leading genomics companies, including Signature Genomics, Quest Diagnostics, CombiMatrix, Invitae, and now Bionano Laboratories. His work has focused on understanding the genomic basis of Mendelian disorders, genotype-phenotype correlations, and the utilization of new technologies to understand the nature, frequency, and phenotypic impact of human genomic structural variation.Read More
Dr. Serrano earned his B.S. in Physics and Ph.D. in Biochemistry and Molecular Biology at the Quillen College of Medicine at East Tennessee State University. He completed his clinical genetics fellowship at the University of Utah – ARUP Laboratories and is board certified in Clinical Cytogenetics by the American Board of Medical Genetics and Genomics. Dr. Serrano enjoys the unique opportunity to work closely with genetic counselors, genomics scientists, bioinformaticians, clinicians, and other professionals to bring timely and comprehensive genetic diagnostic to patients. Dr. Serrano is passionate about improving efficiency in the analysis, curation, interpretation, and reporting of genetic data so that it can affordably reach the world.Read More
Senior Director Clinical Services
Megan Martin is a certified genetic counselor who joined the clinical services team in 2011. Over the years, her role has evolved into overseeing the clinical services team while providing guidance around process optimization, emerging technologies, genetic data interpretation, insurance advocacy, and industry trends. Megan received her Bachelor of Science in Molecular Cell Biology from Dominican University of California and a Master of Science in Genetic Counseling from the University of Utah.Read More
National Sales Director, Pediatric Neurodevelopmental Disorders
Jeremy Ritter has spent the last 20 years working as a sales professional in the diagnostic testing industry that includes a long history in both prenatal and pediatric genetics. He joined Bionano Laboratories in 2017 as Territory Manager passionately promoting our testing services to physicians and patients. In 2020, Jeremy was promoted to National Sales Director to lead our US Sales team. Prior to joining Bionano Laboratories, Jeremy held various sales roles with several diagnostic companies that include Laboratory Corporation of America & Progenity, Inc. Jeremy received his bachelor’s degree in Business Administration from Wilmington College.Read More